Ovarian cancer is back in headlines as researchers link gut bacteria shifts to recurrence risk—aiming for precision prevention. A brief bio: ovaries, 3 cell types; origins vary (ovary, fallopian tubes, peritoneum).
A roundup of recent cancer breakthroughs highlights new immunotherapies, targeted drugs and surgical-sparing treatments. The Independent reports on Scolyer’s pioneering work and a landmark NICE decision; The Guardian covers durvalumab’s promise in bladder cancer; Business Insider UK and Reuters summarize ASCO findings on pancreatic and colon cancers, among others.